Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study.
Hughes DJ, Kapiris M, Podvez Nevajda A, McGrath H, Stavraka C, Ahmad S, Taylor B, Cook GJR, Ghosh S, Josephs D, Pintus E, Gennatas S, Bille A, Ryanna K, Santis G, Montes A, Van Hemelrijck M, Karapanagiotou E, Smith D, Spicer J, Georgiou A. Hughes DJ, et al. Among authors: ahmad s. Cancers (Basel). 2022 Dec 9;14(24):6056. doi: 10.3390/cancers14246056. Cancers (Basel). 2022. PMID: 36551542 Free PMC article.
A brief report on the safety study of induction chemotherapy followed by synchronous radiotherapy and cetuximab in stage III non-small cell lung cancer (NSCLC): SCRATCH study.
Hughes S, Liong J, Miah A, Ahmad S, Leslie M, Harper P, Prendiville J, Shamash J, Subramaniam R, Gaya A, Spicer J, Landau D. Hughes S, et al. Among authors: ahmad s. J Thorac Oncol. 2008 Jun;3(6):648-51. doi: 10.1097/JTO.0b013e3181757a60. J Thorac Oncol. 2008. PMID: 18520806 Free article. Clinical Trial.
Adjuvant Breast Radiotherapy at an Academic Centre during the COVID-19 Pandemic: Reassuringly Safe.
Hanumanthappa N, Goldsmith C, Sawyer E, Tutt A, Castell F, Azad G, Mullassery V, Ahmad S, Timbres J, Mera A, Swampillai A, Smith D. Hanumanthappa N, et al. Among authors: ahmad s. Clin Oncol (R Coll Radiol). 2021 Apr;33(4):e221. doi: 10.1016/j.clon.2020.12.013. Epub 2020 Dec 24. Clin Oncol (R Coll Radiol). 2021. PMID: 33388225 Free PMC article. No abstract available.
A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Robinson EJ, Orton M, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. Among authors: ahmad s. EBioMedicine. 2022 Mar;77:103911. doi: 10.1016/j.ebiom.2022.103911. Epub 2022 Mar 3. EBioMedicine. 2022. PMID: 35248997 Free PMC article.
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK.
Banfill K, Croxford W, Fornacon-Wood I, Wicks K, Ahmad S, Britten A, Carson C, Dorey N, Hatton M, Hiley C, Thippu Jayaprakash K, Jegannathen A, Koh P, Panakis N, Peedell C, Pope A, Powell C, Stilwell C, Thomas B, Toy E, Wood V, Yahya S, Zhou SY, Price G, Faivre-Finn C. Banfill K, et al. Among authors: ahmad s. Clin Oncol (R Coll Radiol). 2022 Jan;34(1):19-27. doi: 10.1016/j.clon.2021.10.009. Epub 2021 Oct 28. Clin Oncol (R Coll Radiol). 2022. PMID: 34763964 Free PMC article.
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Greenlay EJ, Orton M, Bunce C, Lunn J, Doran SJ, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. Among authors: ahmad s. NPJ Precis Oncol. 2022 Oct 27;6(1):77. doi: 10.1038/s41698-022-00322-3. NPJ Precis Oncol. 2022. PMID: 36302938 Free PMC article.
A comparison of internal target volume definition by limited four-dimensional computed tomography, the addition of patient-specific margins, or the addition of generic margins when planning radical radiotherapy for lymph node-positive non-small cell lung cancer.
Hughes S, McClelland J, Chandler A, Adams M, Boutland J, Withers D, Ahmad S, Blackall J, Tarte S, Hawkes D, Landau D. Hughes S, et al. Among authors: ahmad s. Clin Oncol (R Coll Radiol). 2008 May;20(4):293-300. doi: 10.1016/j.clon.2007.12.004. Epub 2008 Jan 30. Clin Oncol (R Coll Radiol). 2008. PMID: 18234482
8,189 results